An increase in the cancer stemness-related ALDH+ and CD133+ cell populations was observed in lung adenocarcinomas treated with Wharton's Jelly mesenchymal stem cell CM (WJMSC-CM) [161]. The gene discussed is PROM1; the disease is cancer.